Suppr超能文献

利用聚合酶链反应分析人类白细胞抗原II类多态性。

Analysis of HLA class II polymorphism using polymerase chain reaction.

作者信息

Erlich H, Bugawan T, Begovich A, Scharf S

机构信息

Department of Human Genetics, Roche Molecular Systems Inc, Alameda, Calif. 94501.

出版信息

Arch Pathol Lab Med. 1993 May;117(5):482-5.

PMID:8489336
Abstract

A simple, rapid, and precise method of typing HLA class II polymorphism would be valuable in the areas of disease susceptibility, tissue transplantation, individual identification, and anthropological genetics. Herein, we describe a method of analyzing class II sequence polymorphism based on polymerase chain reaction (PCR) amplification and hybridization with oligonucleotide probes. Many more DNA-defined alleles at the class II loci have been identified than can be distinguished by conventional serologic typing. Consequently, matching transplant donors and recipients by PCR/oligonucleotide typing should reduce graft rejection and graft-vs-host disease. Also, the ability to identify alleles conferring genetic predisposition to specific diseases (eg, insulin-dependent diabetes mellitus) is significantly enhanced by distinguishing the many alleles or "subtypes" within a serologic type (eg, DR4). One valuable property of sequence-based HLA typing strategies, like oligonucleotide probe hybridization, is that they reveal how and where two alleles differ, not simply that they can be operationally distinguished. The nature and location of HLA polymorphisms appears to be critical in disease association studies and are important in tissue typing for transplantation. New alleles at the DRB1, DPB1, and DQB1 loci are likely to be identified as this technology is applied to more and more samples, particularly in nonwhite ethnic groups. A new allele is uncovered as an unusual pattern of probe binding and then confirmed by sequencing. This pattern is observed because class II polymorphism is localized to specific regions and virtually all "new" alleles represent "shuffled" combinations of polymorphic sequences found in previously known alleles. Since these polymorphisms are in the region of probe binding, these new alleles can be detected without increasing the probe panel. Obviously, any new allele with a new polymorphic sequence in a region for which typing probes are not available would not be revealed by oligonucleotide typing. With the PCR primers and probes described here, 7 DQ alpha 1 alleles, 15 DQ beta 1 alleles, 18 DPB1 alleles, and 32 DRB1 alleles are distinguished. Additional primers and/or probes can, of course, increase the allelic discrimination of PCR/oligonucleotide probe typing. These horseradish peroxidase-labeled oligonucleotide probes are stable (> 2 years when stored at 4 degrees C) and the typing system is simple and robust. Although this dot blot/oligonucleotide hybridization procedure is a powerful and precise method of HLA class II typing, the complexity of the procedure increases as the number of probes required for analysis increases.(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

一种简单、快速且精确的HLA II类多态性分型方法在疾病易感性、组织移植、个体识别和人类遗传学领域将具有重要价值。在此,我们描述了一种基于聚合酶链反应(PCR)扩增和与寡核苷酸探针杂交来分析II类序列多态性的方法。通过DNA定义的II类基因座等位基因比传统血清学分型能够区分的要多得多。因此,通过PCR/寡核苷酸分型来匹配移植供体和受体应能减少移植排斥和移植物抗宿主病。此外,通过区分血清学类型(如DR4)中的多个等位基因或“亚型”,识别赋予特定疾病(如胰岛素依赖型糖尿病)遗传易感性等位基因的能力得到显著增强。基于序列的HLA分型策略(如寡核苷酸探针杂交)的一个重要特性是,它们揭示了两个等位基因的差异方式和位置,而不仅仅是它们在操作上可以区分。HLA多态性的性质和位置在疾病关联研究中似乎至关重要,在移植组织分型中也很重要。随着这项技术应用于越来越多的样本,特别是非白种人族群,DRB1、DPB1和DQB1基因座可能会发现新的等位基因。通过观察探针结合的异常模式发现新等位基因,然后通过测序进行确认。之所以观察到这种模式,是因为II类多态性定位于特定区域,实际上所有“新”等位基因都代表了先前已知等位基因中多态性序列的“重排”组合。由于这些多态性位于探针结合区域,无需增加探针组就能检测到这些新等位基因。显然,对于没有分型探针区域中具有新多态性序列的任何新等位基因,寡核苷酸分型都无法检测到。使用此处描述的PCR引物和探针,可以区分7个DQα1等位基因、15个DQβ1等位基因、18个DPB1等位基因和32个DRB1等位基因。当然,额外的引物和/或探针可以增加PCR/寡核苷酸探针分型的等位基因区分能力。这些辣根过氧化物酶标记的寡核苷酸探针很稳定(4℃保存>2年),分型系统简单且可靠。尽管这种斑点印迹/寡核苷酸杂交方法是一种强大而精确的HLA II类分型方法,但随着分析所需探针数量的增加,该方法的复杂性也会增加。(摘要截短至400字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验